The burden of prescription coverage of kidney failure patients in the United States: Is Medicare Part D the answer?

Kidney International

Volumn 69, Issue 7, 2006, Pages 1099-1100

  Radhakrishnan, Jai ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; IMMUNOSUPPRESSIVE AGENT;

ANEMIA; COMORBIDITY; DIALYSIS; DRUG COST; EDITORIAL; HEALTH CARE COST; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; MEDICAID; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

AGED; COST OF ILLNESS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MEDICARE; PRESCRIPTIONS, DRUG; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33645528978     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000275     Document Type: Editorial

References (8)

1. Nickolas TL, Frisch GD, Opotowsky AR et al. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis 2004; 44: 185-197.
2. Medicare Coverage of Kidney Dialysis and Kidney Transplant Services. HealthCare Financing Administration: Baltimore, MD; June 2001.
3. Thomas C. What does it mean for patients? The expanded Medicare coverage of immunosuppressive medications. Nephrol News Issues 2001;Suppl: S15-S17.
4. Shih YC. Effect of insurance on prescription drug use by ESRD beneficiaries. Health Care Financ Rev 1999; 20: 39-54.
5. Paris W, Dunham S, Sebastian A et al. Medication nonadherence and its relation to financial restriction. J Transpl Coord 1999; 9: 149-152.
6. United States Renal Data System. Economic Costs of ESRD. USRDS: Bethesda, MD. 2004.
7. National Kidney Foundation. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. NKF Office of Scientific and Public Policy: Washington, DC. 2004;http://www.kidney.org/news/pubpol/pdf/hr1.pdf.
8. Overhauling Medicare: Medicare modernization act means incremental implementation measures. Capital Kidney Connection [online] 2004; 5(3): 1-3; http://www.kidney.org/news/pubpol/pdf/ckc5_3.pdf.